Skip to main content
Medical information Clinical review pending

Diagnostic Testing

Immunophenotyping by Flow Cytometry CD34 Test

The Immunophenotyping by Flow Cytometry CD34 Test identifies and quantifies CD34+ stem and progenitor cells in blood or bone marrow, aiding in the diagnosis and monitoring of hematological conditions, particularly cancers.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
3 mL (2 mL minimum) whole blood in 1 Lavender Top (EDTA) tube, OR 3 mL (2 mL minimum) whole blood in 1 Green Top (Sodium Heparin) tube, OR 2 mL (1 mL minimum) Bone marrow in 1 Green Top (Sodium Heparin) tube.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is required for this test. Confirm with the laboratory before booking.
Test priceKSh 7,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Immunophenotyping by Flow Cytometry CD34 Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Evaluation of unexplained cytopenias (anemia, leukopenia, thrombocytopenia).
  • ✓Diagnosis and classification of hematological malignancies (e.g., leukemia, lymphoma).
  • ✓Monitoring response to chemotherapy or targeted therapy.
  • ✓Assessment of bone marrow function and regeneration.
  • ✓Evaluation prior to or following stem cell transplantation.
  • ✓Detection of minimal residual disease (MRD) in certain cancers.
02

In plain language

What this test helps you understand

This test helps identify and quantify hematopoietic stem and progenitor cells (CD34+), aiding in the diagnosis, prognosis, and monitoring of hematological malignancies, bone marrow failure syndromes, and response to therapy, including stem cell transplantation.
The Immunophenotyping by Flow Cytometry CD34 Test is a specialized diagnostic tool used primarily in oncology and hematology. This test identifies and quantifies CD34+ stem and progenitor cells, which are crucial for understanding various blood-related conditions, especially cancers. By analyzing these cells in a blood or bone marrow sample, healthcare providers gain valuable information for diagnosis, treatment planning, and monitoring patient progress.

This test specifically measures the number of CD34+ cells. CD34 is a marker found on hematopoietic stem cells, the cells responsible for producing all types of blood cells. Quantifying these cells provides insights into bone marrow function and overall hematological status.

This test is recommended for individuals with unexplained blood count abnormalities (anemia, leukopenia, thrombocytopenia), those undergoing cancer treatment, patients suspected of having blood cancers, and individuals who have received stem cell transplants.

Taking this test offers several benefits, including accurate identification of stem cells, monitoring treatment effectiveness, providing critical information for stem cell transplant evaluations, and supporting informed clinical decisions by oncologists and hematologists.

Results indicate the number of CD34+ cells. Abnormal counts may suggest bone marrow disorders or indicate response to cancer therapy. Discuss your results with your healthcare provider for accurate interpretation and guidance.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is required for this test. Confirm with the laboratory before booking.
Sample3 mL (2 mL minimum) whole blood in 1 Lavender Top (EDTA) tube, OR 3 mL (2 mL minimum) whole blood in 1 Green Top (Sodium Heparin) tube, OR 2 mL (1 mL minimum) Bone marrow in 1 Green Top (Sodium Heparin) tube.
MethodologyFlow Cytometry
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
Results must be interpreted by a qualified healthcare professional in conjunction with the patient's clinical history and other diagnostic tests. The test identifies CD34+ cells but does not provide information on their specific lineage or function.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

CD34 is a protein found on the surface of hematopoietic stem cells and progenitor cells. These cells are responsible for producing all types of blood cells.
This test helps doctors diagnose certain blood cancers, monitor how well cancer treatment is working, and assess the health of the bone marrow.
A sample of blood or bone marrow is collected. Blood is typically drawn from a vein in your arm, or bone marrow may be aspirated from the hip bone.
No special fasting is required for this test. Confirm with the laboratory before booking.
Turnaround time varies. Confirm with the laboratory before booking.
Your doctor will interpret the results based on your individual health situation. An abnormal number of CD34+ cells may indicate a specific condition requiring further investigation.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp